Incremental cost analysis of ambulatory clinic and home-based intravenous therapy for patients with multiple myeloma

PharmacoEconomics

Volumn 19, Issue 8, 2001, Pages 845-854

  Coyte, Peter C ^a,b   Dobrow, Mark J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Hamilton Regional Cancer Centre ^*

^c JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DEVICE; DRUG COST; DRUG INFUSION; FEMALE; HEALTH CARE COST; HOME CARE; HUMAN; LEISURE; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AMBULATORY CARE; ANTI-INFLAMMATORY AGENTS; COSTS AND COST ANALYSIS; DIPHOSPHONATES; FEMALE; HOME CARE SERVICES, HOSPITAL-BASED; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; ONTARIO; RETROSPECTIVE STUDIES;

EID: 0034868916     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119080-00006     Document Type: Article

References (19)

1. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
2. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
3. Selecting infusion devices for use in ambulatory care
4. Evaluation of flow rates for six disposable infusion devices
5. Performance of selected flow-restricting infusion devices
6. A novel device for patient-controlled sedation: Laboratory and clinical evaluation of the baxter intermate LV250 infusor and patient-control module
7. Outpatient chemotherapy with continuous intravenous infusion for patients with recurrent renal cell carcinoma or advanced prostate carcinoma
8. Outpatient use of ceftriaxone: A cost-benefit analysis
9. Self-administration of intravenous antibiotics: An efficient, cost-effective home care program
10. Impact of home infusion therapy on the Colorado Medicaid program budget
11. Savings from outpatient antibiotic therapy for osteomyelitis: Economic analysis of a therapeutic strategy
12. Cost analysis of methlyprednisolone treatment of multiple sclerosis patients
13. Evidence-based medicine: A new approach to teaching the practice of medicine
14. Indirect cost in economic evaluation: The opportunity cost of unpaid inputs
15. Pamidronate: A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone
16. Palliative pamidronate treatment in patients with bone metastases from breast cancer